RESTRUCTURING AND OTHER COSTS

6 Months Ended

Jun. 30, 2020

Restructuring and Related Activities [Abstract]

During the three and six months ended June 30, 2020 the Company recorded restructuring and other costs of $1.3 million and $43.8 million, respectively. During the three and six months ended June 30, 2019, the Company recorded restructuring and other costs of $42.4 million and $62.9 million, respectively.

Restructuring Costs

During the three and six months ended June 30, 2020 the Company recorded net restructuring costs of $2.2 million and $4.5 million, respectively. During the three and six months ended June 30, 2019, the Company recorded net restructuring costs of $10.7 million and $24.9 million, respectively. These costs are recorded in Restructuring and other costs in the Consolidated Statements of Operations and the associated liabilities are recorded in Accrued liabilities and Other noncurrent liabilities in the Consolidated Balance Sheets.

The Company’s restructuring accruals at June 30, 2020 were as follows:


	Severance
(in millions)	2018 and Prior Plans		2019 Plans		2020 Plans		Total

Balance at December 31, 2019	$	7.2	$	19.8	$	—	$	27.0
Provisions	1.0		0.9		4.1		6.0
Amounts applied	(2.2)		(5.6)		(0.3)		(8.1)
Change in estimates	(0.4)		(1.5)		—		(1.9)
Balance at June 30, 2020	$	5.6	$	13.6	$	3.8	$	23.0


	Lease/Contract Terminations
(in millions)	2018 and Prior Plans		2020 Plans		Total

Balance at December 31, 2019	$	0.5	$	—	$	0.5
Provisions	0.3		0.1		0.4
Amounts applied	(0.3)		(0.1)		(0.4)

Balance at June 30, 2020	$	0.5	$	—	$	0.5


	Other Restructuring Costs
(in millions)	2018 and Prior Plans		2019 Plans		2020 Plans		Total

Balance at December 31, 2019	$	2.2	$	0.3	$	—	$	2.5
Provisions	—		0.3		(0.2)		0.1
Amounts applied	—		(0.5)		0.2		(0.3)
Change in estimate	—		(0.1)		—		(0.1)
Balance at June 30, 2020	$	2.2	$	—	$	—	$	2.2

The cumulative amounts for the provisions and adjustments and amounts applied for all the plans by segment were as follows:


(in millions)	December 31, 2019		Provisions		Amounts Applied		Change in Estimates		June 30, 2020

Technologies & Equipment	$	19.1	$	3.1	$	(5.6)	$	(1.9)	$	14.7
Consumables	11.4		1.3		(2.7)		(0.1)		9.9
All Other	(0.5)		2.1		(0.5)		—		1.1
Total	$	30.0	$	6.5	$	(8.8)	$	(2.0)	$	25.7

Other Costs

Other costs for the three months ended June 30, 2020, were a net benefit of $0.9 million. Other costs for the six months ended June 30, 2020 were $39.3 million, which includes an impairment charge of $38.7 million related to indefinite-lived intangible assets. The impaired indefinite-lived intangible assets are tradenames and trademarks related to a reporting unit within the Technologies & Equipment segment. For further details, see Note 12, Goodwill and Intangible Assets.

Other costs for the three and six months ended June 30, 2019 were $31.7 million and $38.0 million, respectively including fixed asset impairments of $32.8 million recorded during the three months ended June 30, 2019.

These other costs are recorded in Restructuring and other costs in the Consolidated Statements of Operations.

The Company announced on August 6, 2020 that it will close its traditional orthodontics business as well as close and restructure certain portions of its laboratory business. The traditional orthodontics business is part of the Technologies & Equipment segment and the laboratory business is part of the Consumables segment. The Company intends to close several of its facilities and reduce its workforce by approximately 4% to 5%. The Company expects to record restructuring charges in a range of $80 million to $90 million for inventory write-downs, severance costs, fixed asset write-offs and other facility closure costs. It is expected that the majority of these charges will be taken during the remainder of 2020. The Company estimates that $45 million to $55 million of the restructuring charges will be non-cash charges related to inventory write-downs and fixed asset write-offs The Company does not expect a significant impact to net sales in the third and fourth quarter of 2020.